Moreover, anti-apoptotic BCL2 proteins promote hedgehog/Gli signaling by enhancing the turnover of a Gli antagonist, SUFU tumor suppressor to inhibit Gli-SUFU interaction, thus increasing the expression of Gli target genes such as BCL2 [34]. The gene discussed is GLI1; the disease is neoplasm.